Macdonald Henderson has advised Emblation, the advanced medical device technology business, specialising in treatments using microwave technology, on a £4M funding package with Virgin Money Venture Debt.

Emblation joins VM Venture Debt portfolio of venture backed, high-growth, IP rich companies.

The funding package follows last year’s acquisition of a new £4 million state-of-the-art headquarters located in Stirling, (also advised on by Macdonald Henderson) marking a significant milestone in the firm’s global expansion journey. The new base will also enhance the company’s production capabilities, as manufacturing will now be in-house.

Emblation has gained recognition for its innovative Swift device, revolutionising the treatment of stubborn skin lesions, with over 350,000 treatments administered worldwide, and its microwave technology is undergoing trials for potential use in treating conditions like cervical and skin cancer.

We wish Emblation every success for the future.


Legal Advisers

For Emblation – Macdonald Henderson (UK) and Squire Patton Boggs (US) LLP (US)

For Virgin Money – DLA Piper Scotland LLP (UK) and DLA Piper LLP (US)